Search Results

Filter
  • 1-10 of  29 results for ""TNF Receptor-Associated Factor 2""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

cIAP1-dependent TRAF2 degradation regulates the differentiation of monocytes into macrophages and their response to CD40 ligand.

  • Authors : Dupoux A; INSERM, Unite Mixte de Recherche 866, Faculté de Médecine, 7 boulevard Jeanne d'Arc, Dijon, France.; Cartier J

Subjects: CD40 Ligand/CD40 Ligand/CD40 Ligand/*metabolism ; Inhibitor of Apoptosis Proteins/Inhibitor of Apoptosis Proteins/Inhibitor of Apoptosis Proteins/*metabolism ; Macrophages/Macrophages/Macrophages/*cytology

  • Source: Blood [Blood] 2009 Jan 01; Vol. 113 (1), pp. 175-85. Date of Electronic Publication: 2008 Sep 30.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.

  • Authors : Guasparri I; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10021, USA.; Bubman D

Subjects: Cell Transformation, Viral*/Cell Transformation, Viral*/Cell Transformation, Viral*/genetics ; Gene Expression Regulation, Leukemic*/Gene Expression Regulation, Leukemic*/Gene Expression Regulation, Leukemic*/genetics; Herpesvirus 4, Human/Herpesvirus 4, Human/Herpesvirus 4, Human/*metabolism

  • Source: Blood [Blood] 2008 Apr 01; Vol. 111 (7), pp. 3813-20. Date of Electronic Publication: 2008 Jan 29.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-4971

Record details

×
Academic Journal

NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.

  • Authors : Zhang B; Department of Biochemistry and Cancer Biology, University of Toledo Health Science Campus, Toledo, OH 43614, USA.; Wang Z

Subjects: Mutagenesis, Site-Directed*; Lymphoma/Lymphoma/Lymphoma/*genetics ; NF-kappa B p52 Subunit/NF-kappa B p52 Subunit/NF-kappa B p52 Subunit/*genetics

  • Source: Blood [Blood] 2007 Jul 15; Vol. 110 (2), pp. 743-51. Date of Electronic Publication: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-4971

Record details

×
Academic Journal

The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation.

  • Authors : Lu LF; Department of Microbiology and Immunology, Dartmouth Medical School and the Norris Cotton Cancer Center, Lebanon, NH 03756, USA.; Ahonen CL

Subjects: B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*cytology ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*physiology ; TNF Receptor-Associated Factor 2/TNF Receptor-Associated Factor 2/TNF Receptor-Associated Factor 2/*metabolism

  • Source: Blood [Blood] 2007 Jul 01; Vol. 110 (1), pp. 193-200. Date of Electronic Publication: 2007 Mar 14.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0006-4971

Record details

×
Academic Journal

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.

  • Authors : Sharma S; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Subjects: Gene Expression Regulation, Neoplastic*; Adenine/Adenine/Adenine/*analogs & derivatives ; CD40 Antigens/CD40 Antigens/CD40 Antigens/*metabolism

  • Source: Blood [Blood] 2021 May 06; Vol. 137 (18), pp. 2481-2494.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020

Record details

×
Academic Journal

miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency.

  • Authors : Lu Y; Translational Medicine Research Center, Affiliated Jiangning Hospital, and Liver Transplantation Center, First Affiliated Hospital, Nanjing Medical University, Nanjing, China; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Cancer Center, Minneapolis, MN

Subjects: Antagomirs/Antagomirs/Antagomirs/*genetics ; Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*prevention & control ; MicroRNAs/MicroRNAs/MicroRNAs/*genetics

  • Source: Blood [Blood] 2016 Sep 08; Vol. 128 (10), pp. 1424-35. Date of Electronic Publication: 2016 Aug 02.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.

  • Authors : Bushell KR; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;

Subjects: Mutation*; Lymphoma, B-Cell/Lymphoma, B-Cell/Lymphoma, B-Cell/*genetics ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*genetics

  • Source: Blood [Blood] 2015 Feb 05; Vol. 125 (6), pp. 999-1005. Date of Electronic Publication: 2014 Dec 02.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD.

  • Authors : Stickel N; Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Spemann Graduate School of Biology and Medicine, and Faculty of Biology, Albert Ludwigs University Freiburg, Freiburg, Germany;

Subjects: Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*metabolism ; MicroRNAs/MicroRNAs/MicroRNAs/*metabolism ; T-Lymphocytes/T-Lymphocytes/T-Lymphocytes/*metabolism

  • Source: Blood [Blood] 2014 Oct 16; Vol. 124 (16), pp. 2586-95. Date of Electronic Publication: 2014 Sep 09.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1.

  • Authors : Fang J; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, USA.; Rhyasen G

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Autophagy/Autophagy/Autophagy/*drug effects ; Boronic Acids/Boronic Acids/Boronic Acids/*pharmacology

  • Source: Blood [Blood] 2012 Jul 26; Vol. 120 (4), pp. 858-67. Date of Electronic Publication: 2012 Jun 08.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2.

  • Authors : Cejas PJ; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.; Walsh MC

Subjects: Cell Differentiation/Cell Differentiation/Cell Differentiation/*immunology ; Interleukin-2/Interleukin-2/Interleukin-2/*immunology ; Signal Transduction/Signal Transduction/Signal Transduction/*immunology

  • Source: Blood [Blood] 2010 Jun 10; Vol. 115 (23), pp. 4750-7. Date of Electronic Publication: 2010 Mar 29.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  29 results for ""TNF Receptor-Associated Factor 2""